Investors of Inspire Medical Systems Urged to Act on Class Action Notice

Class Action Alert for Inspire Medical Systems Investors

Recently, The Gross Law Firm issued an important notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP), encouraging those who incurred losses due to the company’s recent troubles to reach out regarding a pending class action lawsuit. This news primarily targets individuals who purchased shares during the designated class period from August 6, 2024, to August 4, 2025.

Background of the Case

The allegations assert that substantially misleading information was provided by the company's executive team, particularly regarding the launch of the new product, Inspire V. Investors were reportedly misled into believing that the launch was successful while, in reality, the demand for the new product was disappointing. The complaint indicates that healthcare providers were experiencing an excess of inventory and were hesitant to adopt this new treatment option.

Defendants claimed that they had taken all necessary steps to ensure a successful launch; however, evidence suggests they failed to complete essential tasks. These included inadequate training and onboarding for their treatment center customers, incomplete IT system setups necessary for approving customers, and poor coordination regarding insurance claims—especially critical for processing payments. Furthermore, Medicare reimbursement arrangements were not in place at launch, further complicating matters.

Guiding Shareholders

The Gross Law Firm emphasizes that it does not require investors to seek lead plaintiff status in order to participate in any potential recovery stemming from this case. Shareholders are encouraged to register their information via the firm's online submission form, available at their official website, to ensure they receive important updates through a portfolio monitoring software. The deadline to apply as a lead plaintiff is fast approaching—January 5, 2026—so affected investors should act swiftly.

By participating in this class action, investors stand to protect their rights against potentially fraudulent actions conducted by the company that led to artificial inflation of its stock. The Gross Law Firm, a nationally recognized class action law firm, is devoted to defending the rights of investors who have faced losses due to deceit or illegitimate business practices.

Next Steps for Affected Investors

If you are among those who purchased shares during the specified timeline, you should not hesitate to reach out and register your interest. Doing so will allow you to stay informed on the proceedings of the case and possibly recover some of your losses.

For more information, contact:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Investors should remember that there is no cost or obligation to participate; this initiative aims to restore investor confidence and ensure accountability in corporate conduct.